24/7 Clients Support
| Brand Name | SORALIEVA 200MG |
| Composition | Sorafenib Tablets 200mg |
| Manufacture By | Allieva Pharma Private Limited |
| Form | Tablet |
| Packing | Btl (30 tab) |
| Country Of Origin | India |
| Description | SORALIEVA contains Sorafenib, an oral multi-kinase inhibitor. It blocks multiple kinases involved in tumor cell proliferation and angiogenesis, including RAF kinases, VEGFR, and PDGFR, slowing tumor growth. |
| Uses | Sorafenib is used for: 1. Hepatocellular carcinoma (HCC) – unresectable or advanced 2. Renal cell carcinoma (RCC) – advanced or metastatic 3. Differentiated thyroid carcinoma – radioactive iodine-refractor |
| Side Effects | Common side effects: • Hand–foot skin reaction (redness, pain, peeling) • Diarrhea • Fatigue • Hair thinning or hair loss • Hypertension • Loss of appetite Serious side effects: • Severe bleeding • Liver toxicity • Cardiac events • Gastrointestinal perforation (rare) • Severe infections |
| Dosage | • Standard dose: 400 mg orally twice daily (can be adjusted based on tolerance) • Take on an empty stomach (at least 1 hour before or 2 hours after food) • Dose modification may be required in hepatic impairment or side effects |